Direxion Daily S&P Biotech Bull 3X ETF
LABU
8 hedge funds and large institutions have $1.36M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
300% more funds holding
Funds holding: 2 → 8 (+6)
0.08% less ownership
Funds ownership: 0.11% → 0.03% (-0.08%)
48% less capital invested
Capital invested by funds: $2.61M → $1.36M (-$1.25M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.57M |
| 2 |
OPPM
Opus Point Partners Management
New York
|
+$568K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$546K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$24.4K |
| 5 |
Morgan Stanley
New York
|
+$18.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$2M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$24.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $668K | +$1.57M | +514 | New |
|
|
OPPM
2
Opus Point Partners Management
New York
| $241K | +$568K | +186 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $233K | +$546K | +179 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $195K | -$24.4K | -8 | -5% |
|
|
5
UBS Group
Zurich,
Switzerland
| $11K | +$24.4K | +8 | New |
|
|
6
Morgan Stanley
New York
| $8K | +$18.3K | +6 | New |
|
|
DADC
7
D.A. Davidson & Co
Great Falls,
Montana
| $3K | +$9.16K | +3 | New |
|
|
TWA
8
TCI Wealth Advisors
Tucson,
Arizona
| $1K | +$3.05K | +1 | New |
|
|
9
Citigroup
New York
| – | -$2M | -525 | Closed |
|
LABU Hedge Fund Activity: Q3 2015 in Review
8 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2015, worth a combined $1.36M — down 48% from $2.61M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LABU positions and 1 closed out — a net gain of 6 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $1.57M. The largest seller was Citigroup, exiting entirely with an estimated $2M sold.
- 8 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2015, up from 2 in Q2 2015.
- Funds reported $1.36M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2015, down 48% quarter-over-quarter.
- 7 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2015 and 1 closed out, a net change of +6 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2015 was Jane Street, an estimated $1.57M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2015 was Citigroup, an estimated $2M sold.
Based on aggregated 13F filings for Q3 2015.